News | May 11, 2026
Bajaj Healthcare FY26 revenue rises 12.6% to Rs 6,110 million
Strong export-led growth and improved profitability as the company focuses on CNS drug development and global regulatory footprint
Strong export-led growth and improved profitability as the company focuses on CNS drug development and global regulatory footprint
Healthcare leaders, policymakers, hospitals, and patient advocates discuss AI-driven healthcare, digital transformation, quality of life in cancer care
The Union Minister reviewed DST-supported SATHI-BHU facility
India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells
The move targets long-standing bottlenecks in MSC science, including cell-to-cell variability, immunocompatibility concerns, and inefficient manufacturing workflows
Academia-industry partnership to promote indigenous technology commercialization in biotech sector
The biosimilars business generated Rs. 10,431 crore in FY26 revenue, up 16% year-on-year
Clinical guidelines and expert consensus recommend 1.2–1.5 g/kg/day protein intake during therapy to help preserve muscle mass
U.S. business drives strong growth as Lupin reports 57% rise in Q4 U.S. sales and 43% increase in gross profit
The acquisition positions Roche more aggressively in digital pathology and precision diagnostics capabilities
Subscribe To Our Newsletter & Stay Updated
